SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
12 hedge funds and large institutions have $207M invested in Syros Pharmaceuticals, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$38M | |
2 | +$37.8M | |
3 | +$16.5M | |
4 |
RG
Redmile Group
San Francisco,
California
|
+$15.1M |
5 |
BBA
Baker Bros. Advisors
New York
|
+$3.71M |
Top Sellers
No sellers this quarter